Not entirely true.
On wednesday next week PXS front the FDA's pulmonary-Allergy Drugs Advisory Committee to discuss the application. The committee will vote at the end of that meeting.
It is unusual for a positive recommendation to be knocked back by the FDA which then meets in March.
Not entirely true.On wednesday next week PXS front the FDA's...
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
